IMVT Stock Summary and Trading Ideas (Immunovant | NASDAQ:IMVT)

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

What symbol and exchange does Immunovant shares trade?

Immunovant trades on the NASDAQ stock market under the symbol IMVT.

What is Immunovant stock price doing today?

As of December 16, 2025, IMVT stock price declined to $25.87 with 24,045 million shares trading.

What is Immunovant's Beta?

IMVT has a beta of 1.29, meaning it tends to be more sensitive to market movements. IMVT has a correlation of 0.17 to the broad based SPY ETF.

How much is Immunovant worth?

IMVT has a market cap of $5.21 billion. This is considered a Mid Cap stock.

What is the highest and lowest price Immunovant traded in the last 3 year period?

In the last 3 years, IMVT traded as high as $45.58 and as low as $12.72.

What are the top ETFs holding Immunovant?

The top ETF exchange traded funds that IMVT belongs to (by Net Assets): VTI, IWM, VB, XBI, VBR.

Is Immunovant (IMVT) a good investment?

IMVT has underperformed the market in the last year with a return of -1.6%, while SPY returned +13.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in IMVT shares. However, IMVT has outperformed the market in the last 3 month and 2 week periods, returning +66.6% and +13.7%, while SPY returned +3.1% and -0.1%, respectively. This indicates IMVT has been having a stronger performance recently.

What are the support and resistance levels for Immunovant (IMVT)?

IMVT support price is $25.03 and resistance is $26.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMVT shares will trade within this expected range on the day.